Interestingly, recent studies on this cancer model confirmed that treatment with the PERK inhibitor GSK2606414 alone significantly reduced MM cell proliferation in vitro, as well as in vivo, in mouse xenografts models. Here, EIF2AK3 is linked to Miyoshi myopathy.